Large-scale testing (Phase 3)Study completedNCT05899816
What this trial is testing
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)
Who this might be right for
Atopic DermatitisModerate-to-severe Atopic Dermatitis
Amgen 221